Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer
Crossref DOI link: https://doi.org/10.1007/s00795-015-0109-0
Published Online: 2015-05-26
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Maeda, Tetsuyo
Nakanishi, Yoko
Hirotani, Yukari
Fuchinoue, Fumi
Enomoto, Katsuhisa
Sakurai, Kenichi
Amano, Sadao
Nemoto, Norimichi
Text and Data Mining valid from 2015-05-26